An innovative web portal where patients can access information about their medications while in hospital and after leaving hospital has been developed by The Royal Melbourne Hospital Pharmacy Department.
Victorians will benefit from a new digital investment in Melbourne’s Biomedical Precinct with the announcement of $124 million for the new Connecting Care Electronic Medical Record (EMR) program.
A breakthrough in stroke medical research found a drug, traditionally used for heart attacks, dissolves blood clots in the brain faster and more effectively than standard stroke drugs.
Melbourne Health has welcomed the finding of Charles Scerri QC that Melbourne Health responded appropriately to the alleged behaviour of former Chair, Robert Doyle, at a function in 2016.
The RMH’s Medical IT Training Simulator, developed by Senior Biomedical Engineer Simon Cowley, has won 3rd place in the inaugural Australian Biomedical Engineering Innovation Awards (ABEIA).
A breakthrough drug with its origins in Melbourne is driving a major shift in the treatment of a range of blood cancers, with two new clinical trials of chemotherapy-free combinations demonstrating dramatic benefits for patients with hard-to-treat diseases.
Liver cancer in Hepatitis B patients could be detected and treated earlier with Melbourne Health-led research into Hepatitis B splice variants currently underway.
